Abstract
The present rapid expansion of activity in development of peptide and protein drug compounds has provided a major thrust for development of novel technology for their delivery. These compounds have typically very low oral bioavailability (although this elusive goal is sufficiently attractive for it to remain an active area of exploration).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anik, S.T., McRae, G.I., Nerenberg, C., Worden, A., Foreman, J., Hwang, J-Y., Kushinsky, S., Jones, R.E., and Vickery, B., 1984, Nasal Absorption of Nafarelin Acetate, the Decapeptide [D-Nal(2)6]LHRH, in Rhesus Monkeys I, J. Pharm. Sci., 73: 684.
Anik, S.T., Benjamin, E.J., Maskiewicz, R., McRae, G.I., Nerenberg, C., Hwang-Felgner, J., Schneider, J., Worden, A., and Foreman, J., 1986, Nasal Absorption of Nafarelin Acetate in Rhesus Monkeys II: Effect of Formulation Variables. Manuscript in Preparation.
Anik, S.T., and Hwang, J-Y., 1983, Adsorption of D-Nal(2)6LHRH, a Decapeptide, onto Glass and Other Surfaces. Int. J. Pharm., 16: 81.
Beck, L.R., Pope, V.Z., Flowers, C.E. Jr., Cowsar, D.R., Tice, T.R., Lewis, D.H., Dunn, R.L., Moore, A.B., and Gilley, R.M., 1983, Poly(DL-lactide-co-glycolide)/Norethisterone Microcapsules: An Injectable Biodegradable Contraceptive, Biol. of Rep., 28: 186.
Beck, L.R., Cowsar, J.R., Lewis, D.H., Cosgrove, R.J., Riddle, C.T., Lowry, S.L., and Epperly, T., 1979. A New Long-Acting Injectable Microcapsule System for the Administration of Progesterone, Fert. Ster., 31:545.
Hoffman, P.G., Henzl, M.R., Chaplin, M.D., and Nerenberg, C.A., 1986, Phase I and II Studies: Clinical Development of Nafarelin Acetate, Adv. Contracep., In Press.
Kent, J.S., Sanders, L.M., Tice, T.R., and Lewis, D.H., 1984, Microencap-sulation of the Peptide Nafarelin Acetate for Controlled Release, in “Long-Acting Contraceptive Delivery Systems”, G.I. Zatuchni, A. Goldsmith, J.D. Shelton, and J.D. Sciarra, eds., Harper and Row, Philadelphia.
Mason, N.S., Miles, C.S., and Sparks, R.E., 1981, Hydrolytic Degradation of Poly DL-(lactide), Polym. Sci. Technol., 14: 279.
Sanders, L.M., Kent, J.S., McRae, G.I., Vickery, B.H., Tice, T.R., and Lewis, D.H., 1984, Controlled Release of a Leuteinizing Hormone — Releasing Hormone Analogue from Poly (d, l-lactide-co-glycolide) Microspheres, J. Pharm. Sci., 73: 1294.
Sanders, L.M., McRae, G.I., Vitale, K.M., and Kell, B.A., Controlled Delivery of an LHRH Analogue from Biodegradable Injectable Microspheres, 1985, J. Cont. Rel., 2:187.
Vickery, B.H., and McRae, G.I., 1984, LHRH Agonists for Control of Female Fertility: Primate Studies, in: “LHRH and its Analogs. Contraceptive and Therapeutic Applications”, B.H. Vickery, J.J. Nestor Jr., E.S.E. Hafez, eds., MTP Press, Lancaster.
Vickery, B.H., 1986, Comparison of the Potential for Therapeutic Utilities with GNRH Agonists and Antagonists, Endocrine Reviews, 7: 115.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sanders, L.M., Vitale, K.M., Mc Rae, G.I., Mishky, P.B. (1986). Controlled Delivery of Nafarelin, An Agonistic Analogue of LHRH, From Microspheres of Poly (D, L Lactic-Co-Glycolic) Acid. In: Davis, S.S., Illum, L., Tomlinson, E. (eds) Delivery Systems for Peptide Drugs. NATO ASI Series, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9960-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9960-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9962-0
Online ISBN: 978-1-4757-9960-6
eBook Packages: Springer Book Archive